Overview Paxil CR Bioequivalence Study Brazil Status: Completed Trial end date: 2009-10-05 Target enrollment: Participant gender: Summary The study is prospective, open, randomized, crossover in steady state and the volunteers received multiple doses of the drug test and reference (two periods of drug administration). Phase: Phase 1 Details Lead Sponsor: GlaxoSmithKlineTreatments: HalofantrineParoxetine